What is the CVR number of SP MEDITEC A/S?

SP MEDITEC A/S is registered with CVR / Virk under CVR 89388813.

What is the revenue of SP MEDITEC A/S?

SP MEDITEC A/S reported revenue of DKK 43,7M in 2025.

SP MEDITEC A/S employs 74 people as of the latest annual report.

Thomas Bo Iversen is the CEO of SP MEDITEC A/S, in role since 2018.

Søren Ulstrup chairs the board of SP MEDITEC A/S, in role since 2022.

SP MEDITEC A/S's registered address is Fabriksvej 17C.

A/SActive

CVR 89388813Fabriksvej 17C, 3000 HelsingørManufacture of other plastic products· NACE 2226Est. 1979 · 46 years old74 employees

Actively employed in the business

Name	Role	Member since
Current (1)
TB Thomas Bo Iversen Chief Executive Officer	Chief Executive Officer	2018
Former (2)
HM Hans Munkebo Christiansen Audit	Audit	1979 – 1996
FL Finn Louring Management	Management	1979 – 2018

Non-executive oversight

Name	Role	Member since
Current (3)
ML Mogens Laigaard Board of Directors	Board of Directors	2022
SA Susie Ann Spiegelhauer Board of Directors	Board of Directors	2023
SU Søren Ulstrup Chairman	Chairman	2022
Former (8)
FM Frank Marius Gad Deputy Chairman	Deputy Chairman	2022 – 2024
AJ Anders John Krüger Chairman	Chairman	2017 – 2022
FN Freddie Nielsen Board of Directors	Board of Directors	2014 – 2017
SL Susanne Louring Board of Directors	Board of Directors	1996 – 2015
LH Louise Herskind Louring Board of Directors	Board of Directors	2014 – 2017
BS Bjarne Sandager Nielsen Deputy Chairman	Deputy Chairman	2017 – 2022
KF Kennet Filsø Madsen Board of Directors	Board of Directors	2017 – 2024
HH Hanne Herskind Board of Directors	Board of Directors	1996 – 2017

As of last annual report

Shareholder	Type	Ownership	Votes	Since
SP MOULDING A/S	Company	100%	100%	2022
T. B. Iversen Holding ApS	Company	20–24.99%	20–24.99%	2018
MLFM Holding ApS	Company	66.67–89.99%	66.67–89.99%	2019
FLO Holding 2001 ApS	Company	100%	100%	2001
MLAK HOLDING ApS	Company	66.67–89.99%	66.67–89.99%	2018

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.